Given the emerging role for AMPK as a key integrator of cellular metabolism and inflammation27 and studies indicating that high glucose reduces AMPK activation (reviewed in:28, 29), we hypothesized that T2D may impact inflammation by interfering with IL10 signaling. The gene discussed is PRKAA1; the disease is type 2 diabetes mellitus.